Login to Your Account

Inspire's Stock Tanks On Dry Eye Drug's Second Approvable Letter

By Aaron Lorenzo

Monday, December 5, 2005
The FDA dealt another blow to Inspire Pharmaceuticals Inc. with a second approvable letter for its investigational dry eye drug, diquafosol, shaving a third off the company's stock value Friday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription